Talphera, Inc. ( TLPH) - Key Metrics
TLPH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.06 | -$0.05 | -$0.05 |
| 2026Q1 | $0 | -$0.06 | -$0.08 | -$0.08 |
| 2025Q4 | $0 | -$0.09 | -$0.06 | -$0.06 |
| 2025Q3 | $0 | -$0.11 | -$0.06 | -$0.06 |
| 2025Q2 | $0 | -$0.10 | -$0.09 | -$0.09 |
TLPH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.29 |
| 2026Q1 | 0% | -3.10 |
| 2025Q4 | 0% | -3.21 |
| 2025Q3 | 0% | -2.03 |
| 2025Q2 | 0% | -1.15 |
TLPH
Price: $1.08
52 week price:
Earnings Per Share: -0.23 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 58.6 million